No association observed between migraine and risk for vascular dementia in meta-analysis of five cohort studies
THURSDAY, Oct. 7, 2021 (HealthDay News) — Migraine is associated with an increased risk for all-cause dementia and Alzheimer disease, according to research published online Sept. 15 in Acta Neurologica Scandinavica.
Long Wang, M.D., from The Second People’s Hospital of Hefei in China, and colleagues conducted a meta-analysis to examine the potential association between migraine and dementia. Data were included from five published cohort studies, with 249,303 individuals.
The researchers found that migraine was associated with an increased risk for all-cause dementia and Alzheimer disease in a pooled analysis (risk ratios [95 percent confidence intervals], 1.34 [1.13 to 1.59] and 2.49 [1.16 to 5.32], respectively). No association was seen between migraine and risk for vascular dementia (risk ratio, 1.51; 95 percent confidence interval, 0.77 to 2.96).
“Our meta-analysis suggests that migraine is a potential risk indicator for dementia,” the authors write. “More research is needed to corroborate this finding and elucidate possible pathophysiological mechanisms, and importantly, investigate whether treatment of migraine might positively influence the risk of developing dementia.”
Abstract/Full Text (subscription or payment may be required)
NOACs Linked to Slower Cognitive Decline in Patients With A-Fib, Alzheimer Disease 
Updated Recommendations Address Medications to Prevent Migraine in Adults 
Cortical Atrophy in Early-Onset Alzheimer Disease Signature Can Predict Progression to Dementia 
Exercise Link to Dementia Varies by Physical Activity Domain 
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia 
Voice Disorders Linked to Elevated Risk for Incident Cognitive Decline 
Dementia, Stroke Risk Elevated for Those With Severe Mental Illness 
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings 
.jpg)
